According to a study by Frost & Sullivan, Assessing the Full Impact of Essential Tremor on Patient Quality of Life and Finances in the United States, families of patients with ET spend $ 3,715 a year for healthcare of minor tremor, $ 7,632 of moderate tremor, and $ 12,289 of severe tremor. It is also necessary to take into account that essential tremor can be a reason for a person to retire earlier or lose his or her ability to work, and this affects both current and future income. By estimating that, VILIM ball device (based on user survey data) reduces hand shake by an average of 1.5 hours, so it is possible to estimate the extent to which the use of the device helps to reduce the costs associated with the disease. In our calculations, we took into account that the device can be used 3 times a day, so we get an average of 4.5 hours a day when hand tremor is milder, which is 28% of the day (minus 8 hours of sleep out of 24 hours a day) or 56% of the workday (8 hours) time. Based on this data, we can estimate the reduction in treatment and care costs, as well as current and future income loss reduction. We have to consider the fact that the VILIM ball device is certified for the European market, so it was decided to introduce denominators of medical costs and revenues so that the survey data could be adapted to this specific market. For this purpose, the May 2020 report of the Organization for Economic Co-operation and Development Health Care Prices and the comparison of net income in the USA and EU countries were used. The calculations estimated that the average US after-tax income is twice as high as in the European Union, and that health sector prices in the EU are 32% lower than in the US. After considering the differences in prices and income, it was estimated that the use of the VILIM ball device saves 301 Euros per year for treatment and care costs and a drop in income of 88 Euros for future annual income in the case of moderate hand tremor.